The drugs with elamipretide as the principle raw substance have entered the 3rd section of clinical exercise.Elamipretide triacetate is an aromatic-cationic tetrapeptide that targets the mitochondrial intima which is an inhibitor of cardiolipin peroxidase. It effortlessly penetrates mobile membranes